
PubMed:20727215
Annnotations
PubmedHPO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 219-229 | HP_0000716 | denotes | depressive |
T2 | 364-373 | HP_0000716 | denotes | depressed |
NEUROSES
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 13-27 | CHEBI_35469 | denotes | antidepressant |
T2 | 135-149 | CHEBI_35469 | denotes | antidepressant |
T3 | 290-304 | CHEBI_35469 | denotes | antidepressant |
T4 | 603-618 | CHEBI_35469 | denotes | antidepressants |
T5 | 1213-1227 | CHEBI_35469 | denotes | antidepressant |
T6 | 282-286 | PATO_0001470 | denotes | rate |
T7 | 685-690 | PATO_0001470 | denotes | ratio |
T8 | 1074-1084 | PATO_0001470 | denotes | proportion |
T9 | 282-286 | PATO_0000161 | denotes | rate |
T10 | 336-343 | PATO_0000060 | denotes | pattern |
T11 | 685-690 | PATO_0001038 | denotes | ratio |
T12 | 742-748 | PATO_0001309 | denotes | period |
T13 | 987-990 | PATO_0000471 | denotes | low |
T14 | 1292-1295 | PATO_0000471 | denotes | low |
T15 | 999-1009 | CHEBI_5118 | denotes | Fluoxetine |
T16 | 1043-1047 | CHEBI_23888 | denotes | drug |
T17 | 1117-1121 | CHEBI_23888 | denotes | drug |
T18 | 1164-1168 | CHEBI_23888 | denotes | drug |
T19 | 1068-1073 | PATO_0000586 | denotes | large |
T20 | 550-560 | PM3425 | denotes | depression |
T21 | 1259-1269 | PM3425 | denotes | depression |
T22 | 550-560 | PM3425 | denotes | depression |
T23 | 1259-1269 | PM3425 | denotes | depression |
Allie
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
SS1_20727215_6_0 | 663-690 | expanded | denotes | medication possession ratio |
SS2_20727215_6_0 | 692-695 | abbr | denotes | MPR |
AE1_20727215_6_0 | SS1_20727215_6_0 | SS2_20727215_6_0 | abbreviatedTo | medication possession ratio,MPR |